Rydar Equities’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.36M Buy
13,242
+7,222
+120% +$1.68M 1.89% 11
2026
Q1
$1.47M Buy
6,020
+2,045
+51% +$476K 1.14% 31
2025
Q4
$823K Buy
3,975
+1,460
+58% +$289K 0.64% 45
2025
Q3
$468K Sell
2,515
-3,178
-56% -$544K 0.37% 62
2025
Q2
$870K Buy
+5,693
New +$875K 0.69% 44

Other funds holding JNJ

Rydar Equities's JNJ Position: Q2 2026 in Review

Rydar Equities increased its Johnson & Johnson (JNJ) stake by 120% in Q2 2026, buying an estimated $1.68M and bringing the position to 13,242 shares worth $3.36M. The position accounts for 1.89% of the portfolio, ranked #11.

Rydar Equities first reported a position in JNJ in Q2 2025 and has held it in 5 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Rydar Equities held 13,242 shares of Johnson & Johnson worth $3.36M as of Q2 2026.
  • Rydar Equities bought 7,222 Johnson & Johnson shares in Q2 2026, an estimated $1.68M.
  • Johnson & Johnson made up 1.89% of Rydar Equities's portfolio in Q2 2026, its #11 holding.
  • Rydar Equities first reported a position in Johnson & Johnson in Q2 2025 and has held it in 5 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Rydar Equities's 13F filing for Q2 2026, filed 21 Jul 2026.